Takahiro Ota
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan.
Journal: Cancer science
Published: December 22, 2025
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study.
Journal: Translational lung cancer research
Published: March 01, 2024
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study.
Journal: JTO clinical and research reports
Published: May 09, 2023
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.
Journal: JTO clinical and research reports
Published: December 16, 2022
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Journal: Journal of cancer research and clinical oncology
Published: July 23, 2021
Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study.
Journal: Translational lung cancer research
Published: June 09, 2021
Impressive response to nivolumab of non-small-cell lung cancer containing sarcomatoid components.
Journal: Respirology case reports
Published: June 18, 2019
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Journal: Journal of cancer research and clinical oncology
Published: February 21, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026